CHU-LIN TSAICHENG-CHUNG FANGWalson P.D.2020-03-242020-03-2420080196-0644https://scholars.lib.ntu.edu.tw/handle/123456789/478637[SDGs]SDG3acetylcysteine; paracetamol; clinical protocol; drug blood level; drug intoxication; human; letter; liver function test; liver toxicity; priority journal; treatment duration; Acetaminophen; Acetylcysteine; Administration, Oral; Adolescent; Adult; Analgesics, Non-Narcotic; California; Child; Child, Preschool; Female; Hepatitis, Toxic; Humans; Infant; Liver Function Tests; Male; Middle Aged; Overdose; Questionnaires; Risk Assessment; Treatment OutcomeKey Features of the Patient-Tailored N-Acetylcysteine Protocolletter10.1016/j.annemergmed.2007.09.038183593852-s2.0-40949158407